Skip to main content
Log in

New acridine-9-carboxamide linked to 1,2,3-triazole-N-phenylacetamide derivatives as potent α-glucosidase inhibitors: design, synthesis, in vitro, and in silico biological evaluations

  • Original Research
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

α-Glucosidase plays a major role in degradation of carbohydrates to glucose. Therefore, inhibition of this enzyme can be useful in the treatment of carbohydrate-related diseases such as diabetes, cancer, and viral infections. In this study, a new series of acridine-9-carboxamide linked to 1,2,3-triazole-N-phenylacetamide derivatives 5a–m were designed, synthesized, and evaluated as potent α-glucosidase inhibitors. All the synthesized compounds showed excellent to good inhibitory activity against α-glucosidase with IC50 values of 80.3 ± 0.9–564.3 ± 7.2 µM in comparison with standard drug acarbose (IC50 value = 750.0 ± 10.5 μM). Among the synthesized compounds, the most active compound was 3-bromo derivative 5h with inhibitory activity around 9.3 times more than acarbose. this compound was selected for farther biological evaluations. Kinetic study of compound 5h revealed that it is a competitive inhibitor against α-glucosidase. Docking study of compound 5h and its regioisomer 5i with 4-bromo substituent were also carried out in the active site of α-glucosidase to gain an insight into the interaction modes of the synthesized compounds and rationalized structure–activity relationship between these two compounds. Compound 5h was also evaluated against α-amylase and no activity was observed in comparison with acarbose. Furthermore, in vitro cytotoxic assay of compound 5h against human normal and cancer cell lines HDF and MCF-7, respectively, revealed that this compound is a noncytotoxic agent. In silico pharmacokinetic and toxicity assays of compound 5h was performed and obtained results were compared with acarbose.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Scheme 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Abolhasani MH, Safavi M, Goodarzi MT, Kassaee SM, Azin M (2018) Identification and anti-cancer activity in 2D and 3D cell culture evaluation of an Iranian isolated marine microalgae Picochlorum sp. RCC486. DARU J Pharm Sci 26:105–116

    Article  CAS  Google Scholar 

  • Adib M, Peytam F, Rahmanian-Jazi M, Mahernia S, Bijanzadeh HR, Jahani M, Mohammadi-Khanaposhtani M, Imanparast S, Faramarzi MA, Mahdavi M, Larijani B (2018) New 6-amino-pyrido [2, 3-d] pyrimidine-2, 4-diones as novel agents to treat type 2 diabetes: a simple and efficient synthesis, α-glucosidase inhibition, molecular modeling and kinetic study. Eur J Med Chem 155:353–363

    Article  CAS  Google Scholar 

  • Ahmad I (2016) Recent insight into the biological activities of synthetic xanthone derivatives. Eur J Med Chem 116:267–280

    Article  Google Scholar 

  • Aispuro-Pérez A, López-Ávalos J, García-Páez F, Montes-Avila J, Picos-Corrales LA, Ochoa-Terán A, Bastidas P, Montaño S, Calderón-Zamora L, Osuna-Martínez U, Sarmiento-Sánchez JI (2020) Synthesis and molecular docking studies of imines as α-glucosidase and α-amylase inhibitors. Bioorg Chem 94:103491

    Article  Google Scholar 

  • Asemanipoor N, Mohammadi-Khanaposhtani M, Moradi S, Vahidi M, Asadi M, Faramarzi MA, Mahdavi M, Biglar M, Larijani B, Hamedifar H, Hajimiri MH (2020) Synthesis and biological evaluation of new benzimidazole-1, 2, 3-triazole hybrids as potential α-glucosidase inhibitors. Bioorg Chem 95:103482

    Article  CAS  Google Scholar 

  • Asgari MS, Mohammadi-Khanaposhtani M, Kiani M, Ranjbar PR, Zabihi E, Pourbagher R, Rahimi R, Faramarzi MA, Biglar M, Larijani B, Mahdavi M (2019) Biscoumarin-1, 2, 3-triazole hybrids as novel anti-diabetic agents: design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies. Bioorg Chem 92:103206

    Article  CAS  Google Scholar 

  • Bioinformatics and Molecular Design Research Center (2014) PreADMET program. Bioinformatics and Molecular Design Research Center, Seoul, South Korea. http://preadmet.bmdrc.org

  • Chiba S (1997) Molecular mechanism in α-glucosidase and glucoamylase. Biosci Biotechnol Biochem 61:1233–1239

    Article  CAS  Google Scholar 

  • Derosa G, Maffioli P (2012) α-Glucosidase inhibitors and their use in clinical practice. Arch Med Sci 8:899

    Article  CAS  Google Scholar 

  • Dong Y, Zhang B, Sun W, Xing Y (2019) Intervention of prediabetes by flavonoids from Oroxylum indicum. In Bioactive food as dietary interventions for diabetes. Academic Press, pp 559–575

  • Gurram V, Garlapati R, Thulluri C, Madala N, Kasani KS, Machiraju PK, Doddapalla R, Addepally U, Gundla R, Patro B, Pottabathini N (2015) Design, synthesis, and biological evaluation of quinazoline derivatives as α-glucosidase inhibitors. Med Chem Res 24:2227–2237

    Article  CAS  Google Scholar 

  • Hiele M, Ghoos Y, Rutgeerts P, Vantrappen G (1992) Effects of acarbose on starch hydrolysis. Dig Dis Sci 37:1057–1064

    Article  CAS  Google Scholar 

  • Hollander P (1992) Safety profile of acarbose, an α-glucosidase inhibitor. Drugs 44:47–53

    Article  Google Scholar 

  • Howe JD, Smith N, Lee MR, Ardes-Guisot N, Vauzeilles B, Désiré J, Baron A, Blériot Y, Sollogoub M, Alonzi DS, Butters TD (2013) Novel imino sugar α-glucosidase inhibitors as antiviral compounds. Bioorg Med Chem 21:4831–4838

    Article  CAS  Google Scholar 

  • Iqbal S, Khan MA, Javaid K, Sadiq R, Fazal-ur-Rehman S, Choudhary MI, Basha FZ (2017) New carbazole linked 1, 2, 3-triazoles as highly potent non-sugar α-glucosidase inhibitors. Bioorg Chem 74:72–81

    Article  CAS  Google Scholar 

  • Kumar R, Kaur M, Kumari M (2012) Acridine: a versatile heterocyclic nucleus. Acta Pol Pharm 69:3–9

    CAS  PubMed  Google Scholar 

  • Mohammadi-Khanaposhtani M, Rezaei S, Khalifeh R, Imanparast S, Faramarzi MA, Bahadorikhalili S, Safavi M, Bandarian F, Esfahani EN, Mahdavi M, Larijani B (2018) Design, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes. Bioorg Chem 80:288–95.

    Article  CAS  Google Scholar 

  • Pili R, Chang J, Partis RA, Mueller RA, Chrest FJ, Passaniti A (1995) The α-glucosidase I inhibitor castanospermine alters endothelial cell glycosylation, prevents angiogenesis, and inhibits tumor growth. Cancer Res 55:2920–2926

    CAS  PubMed  Google Scholar 

  • Power RF (2003) Enzymatic conversion of starch to fermentable sugars. The alcohol textbook, pp 23–32

  • Qamar R, Saeed A, Saeed M, Shah BH, Ashraf Z, Abbas Q, Seo SY (2018) Synthesis and enzyme inhibitory kinetics of some novel 3-(substituted benzoyl)-2-thioxoimidazolidin-4-one derivatives as α-glucosidase/α-amylase inhibitors. Med Chem Res 27:1528–1537

    Article  CAS  Google Scholar 

  • Rahim F, Zaman K, Taha M, Ullah H, Ghufran M, Wadood A, Rehman W, Uddin N, Shah SA, Sajid M, Nawaz F (2020) Synthesis, in vitro alpha-glucosidase inhibitory potential of benzimidazole bearing bis-Schiff bases and their molecular docking study. Bioorg Chem 94:103394

    Article  CAS  Google Scholar 

  • Sharma P, Dayma V, Dwivedi A, Baroliya PK, Tripathi IP, Vanangamudi M, Chauhan RS, Goswami AK (2020) Synthesis of sulpha drug based hydroxytriazene derivatives: anti-diabetic, antioxidant, anti-inflammatory activity and their molecular docking studies. Bioorg Chem 96:103642

    Article  CAS  Google Scholar 

  • Shimada Y, Nishimura E, Hoshina H, Kobayashi H, Higuchi T, Eto Y, Ida H, Ohashi T (2014) Proteasome inhibitor bortezomib enhances the activity of multiple mutant forms of lysosomal α-glucosidase in pompe disease. JIMD Rep 18:33–39

    Article  Google Scholar 

  • Tsutsumi LS, Gündisch D, Sun D (2016) Carbazole scaffold in medicinal chemistry and natural products: a review from 2010-2015. Curr Top Med Chem 16:1290–1313

    Article  CAS  Google Scholar 

  • Wang G, Wang J, He D, Li X, Li J, Peng Z (2016) Synthesis and biological evaluation of novel 1, 2, 4-triazine derivatives bearing carbazole moiety as potent α-glucosidase inhibitors. Bioorg Med Chem Lett 26:2806–2809

    Article  CAS  Google Scholar 

  • Yang CY, Yen YY, Hung KC, Hsu SW, Lan SJ, Lin HC (2019) Inhibitory effects of pu-erh tea on alpha glucosidase and alpha amylase: a systemic review. Nutr Diabetes 9:1–6

    Article  Google Scholar 

  • Ye GJ, Lan T, Huang ZX, Cheng XN, Cai CY, Ding SM, Xie ML, Wang B (2019) Design and synthesis of novel xanthone-triazole derivatives as potential antidiabetic agents: α-glucosidase inhibition and glucose uptake promotion. Eur J Med Chem 177:362–373

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Maryam Mohammadi-Khanaposhtani or Mohammad Mahdavi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sepehri, N., Asemanipoor, N., Mousavianfard, S.A. et al. New acridine-9-carboxamide linked to 1,2,3-triazole-N-phenylacetamide derivatives as potent α-glucosidase inhibitors: design, synthesis, in vitro, and in silico biological evaluations. Med Chem Res 29, 1836–1845 (2020). https://doi.org/10.1007/s00044-020-02603-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-020-02603-7

Keywords

Navigation